Department of Pharmacy, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Department of Rare Cancer & Head and Neck Medical Oncology, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
BMC Palliat Care. 2023 Jun 7;22(1):66. doi: 10.1186/s12904-023-01162-z.
In our article ?Methadone switching for refractory cancer pain' (BMC palliative care, 2022) we explore the efficacy, safety and economics of methadone in treatment of patients with refractory cancer pain in China. Professor Mercadante provided a better interpretation of data regarding the opioid switching to methadone in the Matters Arising. In this article, we answered the questions in Mercadante et al.'s comments one by one.
在我们的文章《美沙酮转换治疗难治性癌痛》（BMC 姑息治疗，2022 年）中，我们探讨了美沙酮治疗中国难治性癌痛患者的疗效、安全性和经济学。Mercadante 教授在“出现的问题”中对有关阿片类药物转换为美沙酮的数据提供了更好的解释。在本文中，我们逐一回答了 Mercadante 等人评论中的问题。
